The richest man in Nanxian County, Hunan Province: Self-made to build a leading pharmaceutical research and development enterprise, with a net worth of 2.3 billion
Recommended language: Nan County, belonging to Yiyang City, Hunan Province, is located in the border of Xiang'e and Hubei Provinces, the hinterland of Dongting Lake District, and belongs to one of the 36 border counties in Hunan Province, with a permanent population of about 572,000 people as of now.
Nan County was established as a county in the 21st year of the Qing Dynasty and has a long history. A total of 40 cultural sites (including 20 Neolithic sites) and 13 ancient tomb groups were investigated and found throughout the county, and they were previously selected into the list of "Chinese Folk Culture and Art Towns" in 2018-2020 with the help of ground flower drums.
In terms of economic performance, in 2021, Nanxian achieved a GDP of 26.078 billion yuan, an average annual increase of 7.5% over the 17.11 billion yuan in 2016, and the economic development continued to improve.
It is said that one side of the water and soil to support the other side, the brilliant Nan County has produced many historical celebrities since ancient times, and since the reform and opening up, a very large number of outstanding entrepreneurs have been born.
Today, the author will take you to know a new rich man who came out of Nan County, Hunan Province, Zhu Zhihong.
According to the latest "2021 Hengchang Yaofang Hurun Rich List" released by Hurun Research Institute and liquor brand Hengchang Yaofang, Zhu Zhihong ranked first among the richest people in Nanxian with a wealth of 2.3 billion yuan.
So what is Zhu Zhihong' origin?
Public information shows that Zhu Zhihong, now old, from Nan County, Yiyang, Hunan, has a master's degree. He is currently the actual controller and chairman of Hunan Jiudian Pharmaceutical Co., Ltd.
Jiudian Pharmaceutical, which is at the helm of Zhu Zhihong, is a modern pharmaceutical enterprise dedicated to drug research and development, production and sales, and its products mainly include four categories: pharmaceutical preparations, APIs, pharmaceutical excipients and plant extracts. The company adheres to the development of "preparation-API-pharmaceutical excipient integration" and creates vertical integration advantages, and has completed the all-round layout of pharmaceutical preparations, traditional Chinese medicines, APIs, pharmaceutical excipients, pharmaceutical business and other industries.
Starting from scratch, boldly starting a business and counterattacking life, Zhu Zhihong's road of hard work
Zhu Zhihong, born in September 1962 in a poor rural family in Hunan, because the family is really poor, Although Zhu Zhihong likes to study, but because he has no money, he was forced to drop out of junior high school to become a carpenter.
After the domestic college entrance examination was resumed, Zhu Zhihong was admitted to Hunan Normal University through hard work, and then entered Nanxian No. 1 Middle School as a teacher, and finally had hope in life.
During his teaching tenure, Zhu Zhihong continued his postgraduate studies, received a master's degree from Lanzhou University at the age of 27, and entered the Hunan Institute of Pharmaceutical Industry.
Until the end of the 1990s, the spring breeze of domestic reform and opening up has blown all over the land, and Zhu Zhihong, who was already full of wings at that time, deeply felt the opportunity under the tide of the times, and resolutely decided to resign and go to the sea to start a business, and founded Jiudian Pharmaceutical in 2001.
It is worth mentioning that since the establishment of the enterprise, Zhu Zhihong has paid great attention to product research and development and innovation of production process technology and talent accumulation, leading the enterprise to continuously expand the scale of production and accumulate strength. Up to now, Jiudian Pharmaceutical is at the leading level in China in the synthesis technology of ornidazole, sequenidazole, erythromycin, levoxypropiprazine and other APIs.
Under the leadership of Zhu Zhihong, Jiudian Pharmaceutical was listed on the Growth Enterprise Market of the Shenzhen Stock Exchange on October 10, 2017. As of the close of trading on February 25, 2022, Beijing time, the stock price of Jiudian Pharmaceutical was 28.38 yuan, and the total market value was 6.660 billion yuan.
According to the company's latest financial report data, Jiudian Pharmaceutical achieved its main revenue of 1.13 billion yuan in the first three quarters of 2021, up 71.98% year-on-year; the net profit attributable to the mother was 169 million yuan, up 206.62% year-on-year, and the performance was very eye-catching.
The company officially expects Jiudian Pharmaceutical to achieve a net profit attributable to shareholders of the listed company of 195 million yuan to 218 million yuan in the whole year of 2021.
Conclusion: From an ordinary rural child, through continuous learning and bold entrepreneurship, to now become a leader in the pharmaceutical field, Zhu Zhihong's life experience can be described as very inspiring.
I don't know if everyone is optimistic about the future development of Jiudian Pharmaceutical?